Greyson International, Inc. Appoints Director of Medical Products
Boca Raton, Fla. – May 26, 2009 – Greyson International, Inc. (GYSN.PK) announced today that it has appointed Dr. Daniel Ettedgui, D.O., as its Director of Medical Products.
Ettedgui is a practicing physician in Florida, specializing in physical medicine and rehabilitation. He is board certified by the American Board of Physical Medicine and Rehabilitation, and a is member of the American Academy of Pain Management and the American Academy of Physical Medicine and Rehabilitation, among others. Ettedgui is a graduate of Nova Southeastern University and Davidson College.
A newly created position, the Director of Medical Products will work to research and develop topical products, both prescription-based and over-the-counter, many of which will feature Trilexon®, a delivery system designed by Greyson that improves effectiveness of topical applications. Trilexon® recently received trademark approval. Products developed by the Director of Medical Products will be fully owned by Greyson International.
“By seeing patients on a daily basis and addressing the issue of pain management, Dr. Ettedgui is highly familiar with the need for and efficacy of topical pain medications,” said Greyson International CEO Harvey Tauman. “His expertise will allow us to explore all the medically related products that can benefit from the addition of Trilexon® as well as other delivery systems developed by Greyson.”
“I am thrilled to be working with Harvey Tauman, an experienced leader, and Greyson International,” said Ettedgui. “I believe Trilexon® could amplify and improve existing topical applications. The company is already developing cosmetic products featuring Trilexon®; why not use it for medicinal purposes as well?”
Ettedgui added, “There are so many products that could benefit from Trilexon®, such as transdermal narcotics, anti-inflammatories and transdermal vitamin therapies, just to name a few. The possibilities are nearly endless, which is what makes my role as Director of Medical Products and the future for Greyson International so exciting.”
About Greyson International, Inc.
Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonproducts.com.
This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.